Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

348 results

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

25 Aug 2022

In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...

Nicola Ryan

Reviewer

Nicola Ryan
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

24 Aug 2022

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Simone Fezzi

Reviewer

Simone Fezzi
M. Pighi

Reviewer

Michele Pighi
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

14 Aug 2022

The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.

Nicola Ryan

Reviewer

Nicola Ryan
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

PCRonline @ ESC Congress 2022: the interventional cardiology perspective!

18 Jul 2022

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

PCRonline @ ESC Congress 2022

Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

06 Jul 2022

The CASTLE trial is a randomised multicentre prospective non-inferiority trial comparing ultra-thin strut bioresorbable polymer and thin strut durable polymer drug eluting stents implanted with intracoronary imaging guidance.

Nicola Ryan

Reviewer

Nicola Ryan
Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

Distal versus conventional radial access for coronary angiography and intervention (DISCO RADIAL)

13 Jun 2022

The DISCO RADIAL trial sought to assess the efficacy and safety of distal radial access (DRA) compared with conventional transradial access (TRA) with systematic implementation of best prevention methods for the reduction of radial artery occlusion (RAO).

Reviewer

Aaysha Cader

Reviewer

Ali Nazmi Calik
Distal versus conventional radial access for coronary angiography and intervention (DISCO RADIAL)

Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE

08 Jun 2022

The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.

Nicola Ryan

Reviewer

Nicola Ryan
Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE

Biolimus-coated balloon in small-vessel coronary artery disease - The BIO-RISE CHINA study

07 Jun 2022

This trial aimed to assess the safety and efficacy of a biolimus coated balloon in patients with small vessel CAD undergoing PCI.

Nicola Ryan

Reviewer

Nicola Ryan
Biolimus-coated balloon in small-vessel coronary artery disease - The BIO-RISE CHINA study

Calcified lesions: which tools do you choose?

20 May 2022 – From EuroPCR 2022

Have you ever wondered what tools to use when faced with calcified lesions? Discover a step-by-step CT-guided PCI of complex calcific lesion, the use of Orbital Atherectomy: a relatively new calcium modification technique, additions to the calcium toolbox as well as Rotational Atherectomy!

Calcified lesions: which tools do you choose

Calcifications may still be challenging

20 May 2022 – From EuroPCR 2022

Consult this session to discover a selection of cases concerning challenging calcified lesions, and learn how to deal with some complications, such as: an undilatable lesion after rotational atherectomy, a stent dislodgement, a guidewire-tip-detachment, and much more!

Calcifications may still be challenging